CONCERTA® utilizes osmotic pressure to provide methylphenidate HCl at a managed fee. The process, which resembles a conventional tablet in physical appearance, comprises an osmotically active trilayer Main surrounded by a semipermeable membrane with an instantaneous-launch drug overcoat. The trilayer core is made up of two drug levels containing t